Expert recommendations on hepatitis A vaccination for adults.
10.3760/cma.j.cn501113-20231110-00190
- Collective Name:China Foundation for Hepatitis Prevention and Control
- Publication Type:Journal Article
- Keywords:
Hepatitis A;
Hepatitis A virus;
Infection;
Vaccination;
Vaccine
- MeSH:
Adult;
Child;
Humans;
Hepatitis A/prevention & control*;
Hepatitis A Vaccines;
Vaccination;
Asian People;
China/epidemiology*
- From:
Chinese Journal of Hepatology
2023;31(12):1266-1276
- CountryChina
- Language:Chinese
-
Abstract:
Hepatitis A is a significant global public health concern, with severe clinical symptoms in adult cases that can progress to acute hepatic failure. With the implementation of comprehensive prevention and control measures based on vaccination, the reported incidence of hepatitis A in children has notably decreased in China, while the incidence of hepatitis A in adults has gradually increased. Vaccination against hepatitis A in adults remains a crucial preventive measure. This recommendation is formulated based on the World Health Organization's position paper on hepatitis A vaccines (2022), incorporating the latest domestic and international research advancements and opinions from domestic experts. Its aim is to provide recommendations for hepatitis A vaccination among Chinese adults, offering evidence for public health and vaccination professionals to scientifically use hepatitis A vaccines and maximize their preventive efficacy, thereby enhancing hepatitis A prevention and control efforts.
